eLaws
|
eCases
|
United States Code
|
Federal Courts
|
Sign In
Sign Up
eLaws
eCases »
United States Code
Federal Courts »
Home
»
Rulemaking
» Postmarketing Safety Reporting for Combination Products
Postmarketing Safety Reporting for Combination Products
Document ID:
FDA-2008-N-0424-0001
Document Type:
Proposed Rule
Agency:
Food And Drug Administration
Topics:
No Topics associated with this document
Federal Register Number:
E9-23519
CFR Citation:
21 CFR Part 4
View Document:
Details Information
Document Subtype:
NPR-Notice of Proposed Rule-Making
Received Date:
October 01 2009, at 10:30 AM Eastern Daylight Time
Start-End Page:
50744 - 50758
Page Count:
15
Comment Start Date:
October 1 2009, at 12:00 AM Eastern Standard Time
Comment Due Date:
December 30 2009, at 11:59 PM Eastern Standard Time
Comments
Total:
4
Genentech - Comment
Posted:
11/24/2009
ID:
FDA-2008-N-0424-0002
Comment Period Closed
Dec 30,2009 11:59 PM ET
Valerie Fauvelle - Comment
Posted:
12/03/2009
ID:
FDA-2008-N-0424-0003
Comment Period Closed
Dec 30,2009 11:59 PM ET
MedDRA MSSO - Comment
Posted:
12/16/2009
ID:
FDA-2008-N-0424-0005
Comment Period Closed
Dec 30,2009 11:59 PM ET
Pfizer, Inc. - Comment
Posted:
12/22/2009
ID:
FDA-2008-N-0424-0006
Comment Period Closed
Dec 30,2009 11:59 PM ET
Related Documents
Total:
1
Current Good Manufacturing Practice Requirements for Combination Products
Postmarketing Safety Reporting for Combination Products
Details Information
Comments
Posted: 11/24/2009 ID: FDA-2008-N-0424-0002
Dec 30,2009 11:59 PM ET
Posted: 12/03/2009 ID: FDA-2008-N-0424-0003
Dec 30,2009 11:59 PM ET
Posted: 12/16/2009 ID: FDA-2008-N-0424-0005
Dec 30,2009 11:59 PM ET
Posted: 12/22/2009 ID: FDA-2008-N-0424-0006
Dec 30,2009 11:59 PM ET
Related Documents